Navigation Links
Cephalon First Quarter 2011 Earnings Conference Call Tuesday, May 3, 2011 at 5:00 p.m. EDT
Date:4/6/2011

FRAZER, Pa., April 6, 2011 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering first quarter 2011 results for 5:00 p.m. EDT on Tuesday, May 3, 2011. May 3, 2011 Schedule4:10 p.m. EDT

Q1 2011 results will be distributed by PRNewswire4:50 p.m. EDT

To participate in the conference call, dial 913-312-0867 and refer toConference Code Number 67208985:00 p.m. EDT

Conference call begins promptly. Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on the "Investors" tab, then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until 8 p.m. EDT, May 17, 2011.  To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 6720898.

Additional information presented on the conference call may be made available on the Investors page of the company's website.

Contact: Robert S. (Chip) Merritt
610-738-6376
cmerritt@cephalon.com

Joseph Marczely
610-883-5894
jmarczely@cephalon.com


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cephalon Announces Positive Topline Results From a Phase IV Study of NUVIGIL in Shift Work Disorder
2. Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D.
3. Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.
4. Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely
5. Cephalon Reports Record Earnings and Raises 2010 Guidance
6. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
7. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
8. Cephalon Completes Acquisition of Arana Therapeutics
9. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
10. Cephalon Quarterly Conference Call Invitation
11. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , ... February 24, 2017 , ... Delpor, Inc. (Delpor), ... grant from the National Institute of Mental Health (NIMH) for the further advancement of ... PROZOR technology and is expected to deliver therapeutic levels of olanzapine for ...
(Date:2/24/2017)... Symic Bio, a biopharmaceutical company focused on ... therapeutics, announced today the completion of enrollment for the ... The trial will evaluate the safety and efficacy of ... of restenosis following angioplasty. "We,re pleased ... said Nathan Bachtell , M.D., Chief Medical Officer ...
(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
(Date:2/23/2017)... Calif., Feb. 23, 2017 ... dollars, except per share data, unaudited)Three Months Ended December ... BioMarin Revenue $     ... 22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
Breaking Biology Technology:
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... Report Highlights The global biosurgery ... billion in 2016 at a compound annual growth rate ... Includes - An overview of the global market for ... from 2015 and 2016, and projections of compound annual ... market on the basis of product type, source, application, ...
Breaking Biology News(10 mins):